We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-15.72%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$4.46B
AUM Growth
-$6B
Cap. Flow
-$4.51B
Cap. Flow %
-101.07%
Top 10 Hldgs %
21.21%
Holding
7,134
New
733
Increased
2,939
Reduced
2,324
Closed
739

Top Buys

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$41.1M
2
IWD icon
iShares Russell 1000 Value ETF
IWD
+$25.3M
3
DIA icon
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
+$18.4M
4
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$15.7M
5
XLK icon
State Street Technology Select Sector SPDR ETF
XLK
+$15.4M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$411M
2
MSFT icon
Microsoft
MSFT
+$372M
3
AMZN icon
Amazon
AMZN
+$192M
4
TSLA icon
Tesla
TSLA
+$121M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$111M

Sector Composition

Rank Sector Weight
1 Technology 22.54%
2 Healthcare 10.8%
3 Consumer Discretionary 9.19%
4 Financials 8.28%
5 Communication Services 7.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JNUG icon
3276
Direxion Daily Junior Gold Miners Index Bull 2X ETF
JNUG
$516M
$33K ﹤0.01%
993
+325
+49% +$19K
NRSN icon
3277
NeuroSense Therapeutics
NRSN
$17.1M
$33K ﹤0.01%
9,794
+9,494
+3,165% +$18K
NVMI
3278
Nova
NVMI
$13.1B
$33K ﹤0.01%
+377
New +$37.6K
ADAM
3279
Adamas Trust
ADAM
$909M
$33K ﹤0.01%
2,968
-4,310
-59% -$52.8K
OLMA icon
3280
Olema Pharmaceuticals
OLMA
$920M
$33K ﹤0.01%
8,126
+2,170
+36% +$6.88K
SCYX icon
3281
SCYNEXIS
SCYX
$51.1M
$33K ﹤0.01%
2,261
+2,176
+2,560% +$41.9K
TAP.A icon
3282
Molson Coors Class A
TAP.A
$33K ﹤0.01%
585
+382
+188% +$22.1K
UVE icon
3283
Universal Insurance Holdings
UVE
$1.18B
$33K ﹤0.01%
2,569
+2,216
+628% +$28K
VRDN icon
3284
Viridian Therapeutics
VRDN
$2.49B
$33K ﹤0.01%
2,828
+350
+14% +$4.7K
CATC
3285
DELISTED
CAMBRIDGE BANCORP
CATC
$33K ﹤0.01%
401
+276
+221% +$22.8K
LBAI
3286
DELISTED
Lakeland Bancorp Inc
LBAI
$33K ﹤0.01%
2,247
+1,282
+133% +$19.7K
DCFC
3287
DELISTED
Tritium DCFC Limited Ordinary Shares
DCFC
$33K ﹤0.01%
27
+25
+1,250% +$41.1K
AVTA
3288
DELISTED
Avantax, Inc. Common Stock
AVTA
$33K ﹤0.01%
1,766
+1,146
+185% +$20.8K
PRVB
3289
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$33K ﹤0.01%
8,359
+2,035
+32% +$9.65K
CSII
3290
DELISTED
Cardiovascular Systems, Inc.
CSII
$33K ﹤0.01%
2,276
+1,855
+441% +$32.2K
VORB
3291
DELISTED
Virgin Orbit Holdings, Inc. Common Stock
VORB
$33K ﹤0.01%
8,737
+4,021
+85% +$19.9K
RIBT
3292
DELISTED
RiceBran Technologies
RIBT
$33K ﹤0.01%
4,955
+2,598
+110% +$15.9K
AIV
3293
Aimco
AIV
$378M
$32K ﹤0.01%
4,970
+896
+22% +$5.65K
ALTG icon
3294
Alta Equipment Group
ALTG
$234M
$32K ﹤0.01%
3,602
+3,054
+557% +$33.5K
CEVA icon
3295
CEVA Inc
CEVA
$856M
$32K ﹤0.01%
945
+587
+164% +$20.7K
CRIS icon
3296
Curis
CRIS
$3.76M
$32K ﹤0.01%
81
+33
+69% +$13.8K
DESP
3297
DELISTED
Despegar.com
DESP
$32K ﹤0.01%
+3,928
New +$37.9K
EB
3298
DELISTED
Eventbrite
EB
$32K ﹤0.01%
3,133
+2,120
+209% +$25.3K
ELP
3299
DELISTED
Companhia Paranaense de Energia (COPEL)
ELP
$32K ﹤0.01%
+6,239
New +$35.7K
ESRT icon
3300
Empire State Realty Trust
ESRT
$834M
$32K ﹤0.01%
4,605
+3,396
+281% +$27.6K
130 131
132
133 134

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return

Tower Research Capital (TRC)'s Q2 2022 Portfolio in Review

As of Q2 2022, Tower Research Capital (TRC) held 7,134 positions worth $4.46B, down 57% from $10.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.51B in Q2 2022, closing 739 positions and reducing 2,324 holdings. Its most notable exit was iShares MSCI USA Value Factor ETF, an estimated $13.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Russell 1000 Value ETF worth $23.4M.

  • Tower Research Capital (TRC)'s largest Q2 2022 buy was iShares Russell 1000 Value ETF: 161,690 shares worth $23.4M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q2 2022, an estimated $41.1M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2022 reduction was Apple, cutting an estimated $411M.
  • Tower Research Capital (TRC) fully exited iShares MSCI USA Value Factor ETF in Q2 2022, selling an estimated $13.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 21% of its $4.46B portfolio in Q2 2022.
  • Tower Research Capital (TRC) opened 733 new positions and closed 739 in Q2 2022.
  • Tower Research Capital (TRC)'s portfolio value fell 57% quarter-over-quarter to $4.46B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2022, filed 15 Aug 2022.